Lebanon National Drugs Database
This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
You can search in the form below for information related to drugs including Subsidy percentage
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
| ATC | Name | B/G | Ingredients | Dosage | Form | Price |
|---|---|---|---|---|---|---|
| L01EA01 | IMATINIB NEAPOLIS | G | Imatinib - 100mg | 100mg | Tablet, film coated | 16144207.3296 |
| L01EA01 | IMATINIB SHILPA MESYLATE | G | Imatinib - 100mg | 100mg | Tablet, film coated | 14396132.4948 |
| L01EA01 | IMATINIB SPC | G | Imatinib - 100mg | 100mg | Tablet, film coated | 29473180.56 |
| L01CE02 | IRINOGEN | G | Irinotecan HCl - 100mg | 100mg | Injectable solution | 5239641.9075 |
| L01CE02 | IRINOGEN | G | Irinotecan HCl - 100mg | 100mg | Injectable solution | 5239641.9075 |
| L01CE02 | IRINOTECAN GP PHARM | G | Irinotecan HCl trihydrate - 100mg/5ml | 100mg/5ml | Injectable concentrated solution | 5239641.9075 |
| L01CE02 | IRINOTECAN HYDROCHLORIDE | G | Irinotecan HCl - 100mg/5ml | 100mg/5ml | Injectable concentrate for solution | 2085643.56 |
| L01CE02 | IRINOTECAN THYMOORGAN | G | Irinotecan HCl - 100mg/5ml | 100mg/5ml | Injectable concentrated solution | 6111795.69 |
| L01CE02 | IRNOCAM 100 | G | Irinotecan HCl - 100mg/5ml | 100mg/5ml | Injectable solution | 7320946.6865 |
| L01CE02 | IRINOTECAN THYMOORGAN | G | Irinotecan HCl - 40mg/2ml | 40mg/2ml | Injectable concentrated solution | 2123271.15 |
| L01CE02 | IRNOCAM 40 | G | Irinotecan HCl - 40mg/2ml | 40mg/2ml | Injectable solution | 908693.5 |
| J07CA09 | INFANRIX HEXA | B | Diphteria toxoid purified (Prefilled syringe) - ≥30IU/0.5ml, Tetanus toxoid purified (prefilled syringe) - ≥40IU/0.5ml, Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg/0.5ml, Poliomyelitis virus type 1 antigen (prefilled syringe) - 40D.U./0.5ml, Poliomyelitis virus type 2 antigen(prefilled syringe) - 8D.U./0.5ml, Poliomyelitis virus type 3 antigen (prefilled syringe) - 32D.U./0.5ml, HBs Antigen (prefilled syringe) - 10mcg/0.5ml, H. Influenza type b polysaccharide (Vial) - 10mcg/0.5ml | Injectable suspension | 4230416.19 | |
| J07CA06 | INFANRIX IPV + HIB | B | Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen(Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg, Tetanus toxoid (Prefilled syringe) - ≥40IU, Diphtheria toxoid (Prefilled syringe) - ≥30IU, H. Influenza type b polysaccharide(Vial) - 10mcg | Injectable dry powder+suspension | 3014238.7275 | |
| J07BB02 | INFLUVAC | B | Grippal virus surface antigen 3strains - 15mcgx3strains/0.5ml | Injectable suspension | 573820.7475 | |
| J07BB01 | INFLUVAC TETRA | B | Influenza virus surface antigens inactivated (haemagglutinin and neuraminidase) - 15mcg/4strains/0.5ml | Injectable suspension | 970254.285 | |
| J06BB04 | IMMUNOGLOBULINE HUMAINE DE L'HEPATITE B LFB | BioHuman | Hepatitis B immunoglobulin (human) - 100UI/ml | 100UI/ml | Injectable solution | 6853730.4656716 |
Download the new version of the Ministry of Public Health application and discover new features providing reliable health information
and advanced digital services.
The new version allows you to scan medicine barcodes to verify whether the medication is officially registered with the Ministry of Public Health and distributed through approved official channels, contributing to enhanced patient safety and reducing counterfeit and illegal medicines. In addition to other healthcare services, including:
- Tracking medication records on MediTrack
- Locating the nearest healthcare facility
- Accessing information and statistics on nurseries
- Following the latest health news and updates
The Ministry encourages citizens to rely exclusively on the official application as a trusted source for accurate and reliable health information.
